Post-approval studies (Phase 4)Study completedNCT03331770
What this trial is testing
Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost
Who this might be right for
Primary Open-angle Glaucoma
Laboratorios Poen 103
Showing 17 of 17 results